SCHEMBL6174909

SCHEMBL6174909

CC(c1ccncc1N1CCN(C)CC1)C1(C(C)c2ccncc2N2CCN(C)CC2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 4/20 0.37
MAP4K1 Q92918 1/20 0.37
CYP3A4 P08684 2/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ABL1 P00519 2/20 0.34
KCNH2 Q12809 1/20 0.34
POLB P06746 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTR2C P28335 1/20 0.34
GPR139 Q6DWJ6 1/20 0.33
BCL2A1 Q16548 1/20 0.33
MAPK7 Q13164 1/20 0.33
LIPE Q05469 1/20 0.33
KDM4C Q9H3R0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173352 0.92 CYP3A4 (0.35) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6173842 0.90 PRKDC (0.36) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6175872 0.85 EPHX2 (0.40) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6173429 0.83 POLB (0.41) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6173690 0.82 CYP3A4 (0.41) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6171968 0.81 CYP3A4 (0.36) TRPV4MAP4K1CYP3A4ALDH1A1GAA
SCHEMBL6173283 0.80 CYP3A4 (0.38) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL2941010 0.80 CYP3A4 (0.36) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6173440 0.80 CYP3A4 (0.38) CYP3A4ALDH1A1GAACYP2C9CYP2C19
SCHEMBL6172522 0.80 CYP3A4 (0.40) CYP3A4ALDH1A1GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed